NCT05912998

Brief Summary

Knee arthroscopy using standard portals will be performed in three groups. Complete evaluation of all intra -articular structures will be performed followed by accurate localization of the cartilage defect and measurement of its dimensions. The cartilage lesion grading according to the International Cartilage Repair Society system (ICRS). The patients assigned for the first group will have Liposuction through a minor 1 cm incision on the abdomen to obtain adequate amount of emulsified adipose tissues (50 - 60 cc). Autologous adipose tissue will be mixed with autologous hyaline cartilage obtained from non-weight bearing areas of the knee in prepared mold. The graft will be mixed with fibrin glue and left to solidify a little. After obtaining the fashioned graft from the mold it will be fixed in to the defect site by fibrin glue through mini open approach and stability of the implant fitted in the site will evaluated by gentle cycling of the joint. During the graft preparation, a high tibial osteotomy will be performed. Patients assigned for the second group will have microfracture in association with open wedge high tibial osteotomy. Patients assigned for the third group will have open wedge high tibial osteotomy. Standard titanium T locked plate will be used to fix the open wedge osteotomy in the three groups.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable knee-osteoarthritis

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

June 15, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2025

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

2 years

First QC Date

June 12, 2023

Last Update Submit

June 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical assessment of International Knee Documentation Committee (IKDC) scores

    one year

Study Arms (3)

cartilage regeneration

ACTIVE COMPARATOR

35 patient will have knee arthroscopy and cartilage regeneration technique and high tibial osteotomy

Procedure: cartilage regeneration technique

microfracture

ACTIVE COMPARATOR

35 patient will have knee arthroscopy and microfracture with high tibial osteotomy

Procedure: cartilage regeneration technique

high tibial osteotomy

PLACEBO COMPARATOR

35 patient will have knee arthroscopy and high tibial osteotomy

Procedure: cartilage regeneration technique

Interventions

autologous adipose tissue graft with hyaline cartilage graft mixed with fiberinglu

cartilage regenerationhigh tibial osteotomymicrofracture

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age group 18 to 60 years old.
  • Cartilage defect size range 2-5 cm2.
  • Outer Bridge classification II \& III.
  • Single full thickness symptomatic femoral condyles ulcer.
  • Varus deformity of the affected knee 50 - 100.

You may not qualify if:

  • Advanced knee osteoarthritis.
  • Knee range of motion less than 1000.
  • Ligamentous injury of the affected knee.
  • Recent intra articular injection of any type with in last 6 months.
  • Fracture around the knee.
  • Inflammatory joints disorders.
  • Tumors.
  • Immunocompromised patients.
  • Body mass index \< 35
  • Valgus deformed knee any degree
  • Sever varus deformed knee \< 10 0

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

June 12, 2023

First Posted

June 22, 2023

Study Start

June 15, 2023

Primary Completion

June 15, 2025

Study Completion

June 15, 2025

Last Updated

June 22, 2023

Record last verified: 2023-06